Health Canada approves 1st generic version of Novo Nordisk's Ozempic
Health Canada approved on Tuesday the first generic version of Danish drugmaker Novo Nordisk’s Ozempic drug.
Health Canada approved on Tuesday the first generic version of Danish drugmaker Novo Nordisk’s Ozempic drug.
In a news release, the department said the submission for a generic semaglutide injection by Indian drugmaker Dr. Reddy’s Laboratories has been approved. After a “thorough review of evidence,” Health Canada said it found that the drug met safety, efficacy and quality standards.
“I think it’s a great thing,” said Dr. Kaberi Dasgupta, a physician-scientist and professor of medicine at McGill University.
“These medications are quite expensive and we know with generics, it brings down the prices substantially.”
Patients and doctors have long been awaiting a generic version of the drug, which many Canadians use for Type 2 diabetes and weight loss. A recent survey suggested about three million Canadian adults are currently taking GLP-1 drugs, such as Ozempic or Mounjaro, and that many more would like to, but cost is a barrier.
Read more: https://www.cbc.ca/news/health/ozempic-generic-health-canada-9.7180566
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.